Yubin Cao

ORCID: 0000-0001-8553-1430 · 2 papers in corpus
2022
·doi:10.21203/rs.3.rs-1840484/v1

Background: To evaluate the prognosis of EGFR -mutated non-small-cell lung cancer(NSCLC) patients and accurately target the patient subgroups with best potential outcome greatest, a simpler and more effective model based on readily availab…

article 2021
·doi:10.2139/ssrn.3773015